Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
What Femprox review?
100 shares @ $2.20, REALLY...
Sure looks like they are attempting to hold down PPS
Simon, I have never boasted about a sale over $5.
Show me one time.
You can see every post I have ever made on IHUB by looking at my record.
As for how many shares you're way short on amount and I have been in for about 2 years & on this board for about the same time.
Interesting change in tactics vs. arbitrary rant.
RVL
Well stated.
Happily the product works physiologically and ultimately will sell despite the gyrations to get to this point.
I think the large Pharmas that have bought into this product abroad likely are a bit more informed than folks on this Board (and any other Board) and validate this conclusion.
When sales kick in, PPS will jump and the Darwinian-like process that we have lived with for last few years will reward those of us that have stuck with it.
RVL
You beat me to it with your question. Looking at past trading history. Should continue upward tomorrow
Rvl
Simon,
With the recent bump in PPS paired with your obvious negative view and lack of confidence, why don't you sell your shares and move on to a different stock and Ihub board. If you really own stock and were as negative as you are, just get out. Further, I would happily take your shares just to get the manipulative chatter off of this board.
By the way........Happy New Year to all you longs!!!
RVL
Advice to bashers:
At least use facts that are taken out of context to lead to the conclusions you want us to believe.
Just making stuff up, is unlikely to sway anyone reading IHub APRI blog.
We have come to expect much higher quality manipulation.
RVL
To our Moderators:
Do the individuals that are trying to bash (or pump) simply have the option of creating a new alias so that we can't tell it is the same person?
RVL
The tone and cadence of your statements plus the scattered spelling and grammatical errors are familiar.
I agree it appears you have a few aliases and have spent a good deal of the last year spreading your opinions
On the YMB message board.
Ok, so now we know why APRI was marched down today. Someone was aware of impending news.
How does stock pps get marched downward with vast majority of trades being buys?
Actually looks like block SALE fo 3.6M shares
Apricus Elects Kleanthis G. Xanthopoulos, Ph.D. as New Chairman
SAN DIEGO, Dec. 11, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus" or the "Company") (Nasdaq:APRI) (www.apricusbio.com), today announced that Kleanthis G. Xanthopoulos, Ph.D. has been elected as Chairman of the Company's Board of Directors. Dr. Xanthopoulos succeeds Mr. Rusty Ray in the Chairman role. Mr. Ray will continue to serve as a Director and will assume key roles on the Company's audit, compensation and corporate governance committees of the Board. Dr. Xanthopoulos has been a member of the Apricus Board since 2011.
"I am honored to be elected Chairman of the Apricus Board of Directors during this pivotal point in the Company's evolution," said Dr. Xanthopoulos. "Throughout 2013, Apricus has executed effectively on achieving its key strategic goals, culminating in important regulatory approvals for Vitaros®, a defined regulatory pathway for Femprox® and the potential for significant value creation through the licensing and commercialization of Vitaros® and Femprox®. I look forward to working with management and the Board to strengthen our standing as a leader in the field of men's and women's health, and to ensure the Company continues its record of execution, with the goal of maximizing shareholder value."
Dr. Xanthopoulos is an experienced and visionary leader in the biotechnology and pharmaceutical research industries, with a strong foundation in both operations and corporate development. He is currently President and Chief Executive Officer and a member of the board of directors of Regulus Therapeutics Inc. Prior to joining Regulus Therapeutics Inc. in 2007, Dr. Xanthopoulos was the Managing Director of Enterprise Partners Venture Capital. He co-founded Anadys Pharmaceuticals, Inc., served as President and Chief Executive Officer from 2000 to 2006, and remained a Director until its acquisition by Roche in 2011. Before that, Dr. Xanthopoulos was Vice President at Aurora Biosciences (acquired by Vertex Pharmaceuticals) from 1997 to 2000, and Section Head of the National Human Genome Research Institute from 1995 to 1997. Previously, he was an Associate Professor at the Karolinska Institute, Stockholm, Sweden, after completing a Postdoctoral Research Fellowship at The Rockefeller University, New York.
An Onassis Foundation Scholar, Dr. Xanthopoulos received his B.Sc. in Biology with honors from Aristotle University of Thessaloniki, Greece, and his M.Sc. degree in Microbiology and Ph.D. degree in Molecular Biology from the University of Stockholm, Sweden. Dr. Xanthopoulos is a member of the board of directors of the Biotechnology Industry Organization (BIO) and Zosano Pharma Inc., and is a co-founder and a member of the board of directors of Sente, Inc. Additionally, Dr. Xanthopoulos received the Ernst & Young Entrepreneur of the Year Award in Health Sciences in 2006 and was named Most Admired CEO by the San Diego Business Journal in 2013.
Thank you for the heads up on the sale of your holdings In APRI.
Should provide a good buy opportunity.
But better yet, because you no longer own stock, stop the rhetoric and participation in this Board.
RVL
Agreed, that's why I dumped mine last week. Looks like others have same conclusion
Machiavellian (comparative more Machiavellian, superlative most Machiavellian)
Attempting to achieve their goals by cunning, scheming, and unscrupulous methods.
Iago is the Machiavellian antagonist in William Shakespeare's play, Othello.
Related to the philosophical system of Niccolò Machiavelli. [quotations ?]
Casino,
Did you answer my question and get blocked or just not answer?
RVL
Casino
Answer to low PPS;
Because investors will not support an increase in price till APRI has demonstrated the ability to sell product or be sold to someone that will sell product.
Now, simple question......Why are you here participating on this Board?
RVL
Thanks for the insight Court
Phase I (small number of healthy volunteers; in certain cases, i.e. virology/oncology, also patients)
Phase I studies are designed to allow scientists and medical doctors to understand what effects an investigational compound has in human subjects. The goal is to study what happens to the investigational compound in the body from the time it is swallowed or injected until it is excreted, when it is excreted and how the human body reacts to the new compound from a safety and tolerability point of view. Study participants are monitored for the occurrence and severity of any side effects that they may experience.
Phase II
Phase II studies are designed to evaluate the safety and efficacy of an investigational compound in patients with a specific disease or condition. Phase II trials are typically conducted in a group of patients who are usually selected based upon being at the same stage of a disease. The patients are given various doses of the compound and closely monitored to compare the effects and to determine the safest dosing regimen. In many instances, multiple Phase II studies are conducted to test the compound in a variety of patient populations or indications.
Phase III
Phase III studies are designed to confirm the safety and efficacy of an investigational compound, and the dosage regimen chosen, in large numbers of patients with a specific disease or condition. These studies, as in the earlier phases, may involve one or more 'treatment arms', which allow the investigational drug to be compared to other available treatments, or to be tested for effectiveness in combination with other therapies. The safety and efficacy of the new compound is compared to that of the currently accepted standard treatment. Information obtained from Phase III studies is used to determine how the compound is best prescribed to patients in the future. The complete information available on the new compound is submitted to Health Authorities.
Phase IV
Phase IV studies take place after the drug has been approved for marketing and are designed to provide broader experience in evaluating the safety and effectiveness of the new medicine in larger numbers of patients, subpopulations of patients, and to compare and/or combine it with other available treatments. These studies are designed to evaluate the long-term effects of the drug. Under these circumstances, less common adverse events may be detected.
WOW,
Please don't make comments regarding Phase 1,2,3 and FDA unless you actually have done research or are a content expert, or have access to information from the source.
Thanks DG
I am just tired of the old YMB APRI rant.
This constant, seemingly illogical stream of thought (from we relatively small investors perspective) appears to have but one purpose hold stock and volume down while creating doubt in current and potential investors minds.
Dimitrios, i hope you continue to factually refute each "opinion" put forth.
Because I don't see a way to stop this effort.
(Other than APRI pps jump)
RVL
Admittedly I am no Carl Icahn but, being aware of my position in the investment universe, I repeat my comments from 11/15.
I do NOT support your proposal that we, the followers of a BLOG , create a groundswell to get rid of management at a publicly traded company. Has this ever happened? with a successful outcome, where board/ executives are let go, new & better leaders , then stock does significantly better?
We are merely uninformed/ speculative players guessing what the facts are behind closed doors.
I am personally down significantly on my initial investment, but believe in pharmacology & science behind product. Realistically, if we don't like something the company is doing, get out of investment in Apricus.
We CAN research products, observe company, and adapt personal investment strategy.
RVL
I do NOT support your proposal that we, the followers of a BLOG , create a groundswell to get rid of management at a publicly traded company. Has this ever happened? with a successful outcome, where board/ executives are let go, new & better leaders , then stock does significantly better?
We are merely uninformed/ speculative players guessing what the facts are behind closed doors.
I am personally down significantly on my initial investment, but believe in pharmacology & science behind product. Realistically, if we don't like something the company is doing, get out of investment in Apricus.
We CAN research products, observe company, and adapt personal investment strategy.
RVL
So, "They" took pps down to load up, while shaking the uninformed up to sell their position?
Does anyone other than Beach and Court think the participants of this Board should focus our collective efforts repetitively on why management is bad?
Seriously, other than two or three individuals,
Does anyone else think we should spend significant time, effort, thought, on this topic?
Please voice an opinion.
RVL
No, it's pretty much all of us on planet.
No, still long position that I added to last week.
Last response.
Dimitrios,
I am sorry I am going to have to abandon you. The banter added by the two new "experts" that are continuously on APRI/ihub is more than I can bear. Their insightful commentary and intellectually stimulating premises are just too much.
I stopped looking at the YMB. Now I am done with ihub.
You are on your own to reply to the constant barrage of @&$#%€.
I am out.
Good luck
RVL
So, two new SEC notices,
What does this mean?
Anyone?
http://ih.advfn.com/p.php?pid=nmona&article=59564835
So, is the whole INNV team Apricus rejects?
Are Stem cells considered to be a "Medical Device"?
Biggie,
If you don't believe in stock or management, why are you here?
If you can not contribute to content and information but are intent on your bashing rant based on what now appears to be bad intentions, sell your stock (if you actually own any), and go back to bashing a different stock on YMB.
You know this is a stem cell company, Right?
DG,
Great find.
Thanks
RVL
Make up your mind...........here is your earlier post from today:
"I'm buying more shares today...If Upper Management has invested so much of their personal wealth into this company they must be extremely confident in the technology. I know these are turbulent times but stick with it. I'm praying it'll be worth it at the end for all of us...Either we become millionaires or we lost money that we can afford to lose. If you're one of those investors that invest more than you should have then you have every reason to panic. Invest wisely."
I just listened to the presentation.
I believe Pascoe did a great job in communicating the situation and upside for Vitaros & Femprox.
Finally, someone who will represent Apricus that will engender confidence and trust.
That will be extremely important in generating Institutional investors.
Lot's of milestones in short term & long term
Here we go.......
How many shares?